Skip to Main Content

Paper Details

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.
Nat Commun
8
2023
Author NameAffiliation
Jeffrey L WranaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Jeffrey L WranaUniversity of Toronto
Philippe P RouxInstitute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Philippe P RouxUniversite de Montreal
J??ri ReimandUniversity of Toronto
J??ri ReimandOntario Institute for Cancer Research
Hartland W JacksonLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Hartland W JacksonUniversity of Toronto
Daniel SchramekLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Daniel SchramekUniversity of Toronto
  • 1 - 10

Datasets

Release 1.2